AIM: First, to compare the characterization of neurocognitive deficits in milder stages of HIV-associated neurocognitive disorder (HAND) derived from existing dementia rating scales of the American Academy of Neurology (AAN) and Memorial Sloan Kettering (MSK) with the 2007 consensus ('Frascati') classification. Second, to identify potential sociodemographic and clinical predictors of HAND progression during 1-year follow-up. METHODS: 104 HIV-infected subjects in an existing cohort system were evaluated with a medical history, exam, neuropsychological test battery and functional assessments. The degree of HAND was rated using the AAN, MSK and Frascati scales. The degree of concordance among these scales was determined. In addition, 45 subjects were reassessed for changes in their neurocognitive status at 1-year follow-up. Associations between age, education, sex, depression ratings, substance abuse, race, hepatitis C serostatus, CD4 count and progression of HAND were examined. RESULTS: There was excellent concordance (gamma > 0.8) among the Frascati, MSK and AAN ratings. Subjects rated as having minor cognitive motor disorder on the AAN scale (n = 45) were evenly split between Frascati rating of asymptomatic neurocognitive impairment (n = 24) and mild neurocognitive disorder (n = 21). At 1-year follow-up of 45 subjects, 31% had worsened, 13% had improved and 56% were stable. Predictors of progression included age older than 50 years (odds ratio: 5.57; p = 0.013) and female gender (odds ratio: 3.13; p = 0.036). CONCLUSION: The Frascati HAND rating scale has excellent concordance with previous neurocognitive rating scales and can be used to better characterize milder stages of cognitive impairment. Older individuals and women appeared to be more likely to show neurocognitive progression.
AIM: First, to compare the characterization of neurocognitive deficits in milder stages of HIV-associated neurocognitive disorder (HAND) derived from existing dementia rating scales of the American Academy of Neurology (AAN) and Memorial Sloan Kettering (MSK) with the 2007 consensus ('Frascati') classification. Second, to identify potential sociodemographic and clinical predictors of HAND progression during 1-year follow-up. METHODS: 104 HIV-infected subjects in an existing cohort system were evaluated with a medical history, exam, neuropsychological test battery and functional assessments. The degree of HAND was rated using the AAN, MSK and Frascati scales. The degree of concordance among these scales was determined. In addition, 45 subjects were reassessed for changes in their neurocognitive status at 1-year follow-up. Associations between age, education, sex, depression ratings, substance abuse, race, hepatitis C serostatus, CD4 count and progression of HAND were examined. RESULTS: There was excellent concordance (gamma > 0.8) among the Frascati, MSK and AAN ratings. Subjects rated as having minor cognitive motor disorder on the AAN scale (n = 45) were evenly split between Frascati rating of asymptomatic neurocognitive impairment (n = 24) and mild neurocognitive disorder (n = 21). At 1-year follow-up of 45 subjects, 31% had worsened, 13% had improved and 56% were stable. Predictors of progression included age older than 50 years (odds ratio: 5.57; p = 0.013) and female gender (odds ratio: 3.13; p = 0.036). CONCLUSION: The Frascati HAND rating scale has excellent concordance with previous neurocognitive rating scales and can be used to better characterize milder stages of cognitive impairment. Older individuals and women appeared to be more likely to show neurocognitive progression.
Authors: X Liu; K Marder; Y Stern; G Dooneief; K Bell; G Todak; M Joseph; W Elsadr; J B Williams; A Ehrhardt; Z Stein; R Mayeux Journal: J NeuroAIDS Date: 1996
Authors: F H Bouwman; R L Skolasky; D Hes; O A Selnes; J D Glass; T E Nance-Sproson; W Royal; G J Dal Pan; J C McArthur Journal: Neurology Date: 1998-06 Impact factor: 9.910
Authors: R J Ellis; K Hsia; S A Spector; J A Nelson; R K Heaton; M R Wallace; I Abramson; J H Atkinson; I Grant; J A McCutchan Journal: Ann Neurol Date: 1997-11 Impact factor: 10.422
Authors: E A Childs; R H Lyles; O A Selnes; B Chen; E N Miller; B A Cohen; J T Becker; J Mellors; J C McArthur Journal: Neurology Date: 1999-02 Impact factor: 9.910
Authors: Andrea De Luca; B C Ciancio; D Larussa; R Murri; A Cingolani; M G Rizzo; M L Giancola; A Ammassari; L Ortona Journal: Neurology Date: 2002-08-13 Impact factor: 9.910
Authors: J C McArthur; D R Hoover; H Bacellar; E N Miller; B A Cohen; J T Becker; N M Graham; J H McArthur; O A Selnes; L P Jacobson Journal: Neurology Date: 1993-11 Impact factor: 9.910
Authors: Ronald J Ellis; David J Moore; Meredith E Childers; Scott Letendre; J Allen McCutchan; Tanya Wolfson; Stephen A Spector; Karen Hsia; Robert K Heaton; Igor Grant Journal: Arch Neurol Date: 2002-06
Authors: Gary B Fogel; Susanna L Lamers; Andrew J Levine; Miguel Valdes-Sueiras; Michael S McGrath; Paul Shapshak; Elyse J Singer Journal: J Neurovirol Date: 2014-11-18 Impact factor: 2.643
Authors: David E Vance; Pariya L Fazeli; Andres Azuero; Virginia G Wadley; Michael Jensen; James L Raper Journal: Res Nurs Health Date: 2017-12-20 Impact factor: 2.228
Authors: Nishiena S Gandhi; Richard L Skolasky; Katherine B Peters; Richard T Moxley; Jason Creighton; Heidi Vornbrock Roosa; Ola A Selnes; Justin McArthur; Ned Sacktor Journal: J Neurovirol Date: 2011-03-25 Impact factor: 2.643
Authors: Thep Chalermchai; Victor Valcour; Pasiri Sithinamsuwan; Suteeraporn Pinyakorn; David Clifford; Robert H Paul; Somporn Tipsuk; James L K Fletcher; Victor Degruttola; Silvia Ratto-Kim; Nicholas Hutchings; Cecilia Shikuma; Jintanat Ananworanich Journal: J Neurovirol Date: 2013-03-13 Impact factor: 2.643
Authors: Eric Andrius Coelho Duarte; Maria Luiza Benevides; André Luiz Pereira Martins; Edson Pillotto Duarte; Ana Beatriz Santandrea Weller; Laura Oliveira Coutinho de Azevedo; Maria Emília Rodrigues de Oliveira Thaís; Jean Costa Nunes Journal: Neurol Sci Date: 2020-09-14 Impact factor: 3.307
Authors: Hilda Azimi; Kristin M Gunnarsdottir; Sridevi V Sarma; Alyssa A Gamaldo; Rachel M E Salas; Charlene E Gamaldo Journal: Annu Int Conf IEEE Eng Med Biol Soc Date: 2020-07